Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
|Articles|August 16, 2006
IAC: Fighting a No Longer Unbeatable FoeA MULTIMEDIA REPORT -- Day 3
Author(s)Zach Wise
TORONTO -- This Special Report from Zach Wise, a contributing videographer for MedPage Today, provides a multimedia portrayal of the activities at the 16th Annual International AIDS Conference here.
Advertisement
Advertisement
Related to this article
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Advertisement
Advertisement
Trending on Patient Care Online
1
HIV Testing Before and During PrEP: Getting It Right
2
9 Drugs Approved for Primary Care: Q3 2026
3
Immunizing Against Pain and Fear: Rethinking the Vaccination Experience
4
Starting the HIV PrEP Conversation in Primary Care and Pharmacy
5